CLINICAL_TRIALS
trial_result
· 2012-09-20
Clinical Trial Update: Comparing Efficacy Between Anti-microtubule and Non-anti-microtubule as 3th Therapy After 2nd Line EGFR-TKI Therapy
Summary
A completed clinical trial compared anti-microtubule therapy with non-anti-microtubule therapy as third-line treatment after failure of a second-line EGFR-TKI i…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: AstraZeneca | Conditions: Cancer | Status: COMPLETED